...
首页> 外文期刊>Research journal of pharmacy and technology >Exploration of a- amylase Inhibitor producing marine actinobacteria and evaluation of its antioxidant and antimicrobial activities -In vitro study
【24h】

Exploration of a- amylase Inhibitor producing marine actinobacteria and evaluation of its antioxidant and antimicrobial activities -In vitro study

机译:产海洋放线菌的α-淀粉酶抑制剂的探索及其抗氧化和抗菌活性的评价-体外研究

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study is to explore the a-amylase enzyme inhibitor producing of actinobacteria from salt pan soil sample collected from coastal areas of Kothapattanam, Ongole, Andhra Pradesh, India. Among 28 colonies, only 3 acclimatized actinobacterial isolates (VITISB-3, VITISB-9 and VITISB-23) showed potency during primary screening technique. The isolates were inoculated in production media for secondary screening and bioactive compound extraction using different solvents of varying polarity. The ethyl acetate extracts of VITISB-23 and VITISB-3 isolates showed significant a-amylase inhibition activity while VITISB-9 showed less activity. These isolates were further screened for antimicrobial activity and free radical scavenging antioxidant potential. Among these isolates, VITISB-23 and VITISB-3 showed good antimicrobial activity while the other isolate, VITISB-9 showed moderate inhibition activity. VITISB-23 showed antimicrobial activity against all the pathogenic test organisms used in the study. In DPPH antioxidant assay, the isolate VITISB-23 showed a 96% free radical scavenging property, where VITISB-3 showed more than 80%. Based on these results we concluded that VITISB-23 possess potential biological activity and can be further studied for the isolation of new anti-diabetic compound and also for future commercial prospects in pharmaceutical industry for the formulation of medicinal drags.
机译:这项研究的目的是从印度安得拉邦昂戈尔科萨塔塔南沿海地区的盐田土壤样品中探索放线菌的α-淀粉酶抑制剂的生产。在28个菌落中,只有3个适应性放线菌分离株(VITISB-3,VITISB-9和VITISB-23)在初次筛选技术中表现出效价。将分离物接种在生产培养基中,以便使用不同极性的不同溶剂进行二次筛选和生物活性化合物提取。 VITISB-23和VITISB-3分离物的乙酸乙酯提取物显示出显着的α-淀粉酶抑制活性,而VITISB-9显示出较低的活性。进一步筛选了这些分离物的抗菌活性和清除自由基的抗氧化能力。在这些分离株中,VITISB-23和VITISB-3显示了良好的抗菌活性,而其他分离株VITISB-9显示了中等的抑制活性。 VITISB-23对研究中使用的所有致病性测试生物均显示出抗菌活性。在DPPH抗氧化剂测定中,分离物VITISB-23显示出96%的自由基清除性能,而VITISB-3显示出超过80%的自由基清除性能。基于这些结果,我们得出结论,VITISB-23具有潜在的生物学活性,可以进一步研究以分离出新的抗糖尿病化合物,并且还可以用于制药业中药物制剂的未来商业前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号